Found: 56
Select item for more details and to access through your institution.
Synergistic interaction between sunitinib and docetaxel is sequence dependent in human non-small lung cancer with EGFR TKIs-resistant mutation.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2011, v. 137, n. 9, p. 1397, doi. 10.1007/s00432-011-1009-x
- By:
- Publication type:
- Article
Myeloid PTEN loss affects the therapeutic response by promoting stress granule assembly and impairing phagocytosis by macrophages in breast cancer.
- Published in:
- Cell Death Discovery, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41420-024-02094-0
- By:
- Publication type:
- Article
A randomized phase 3 trial of Gemcitabine or Nab-paclitaxel combined with cisPlatin as first-line treatment in patients with metastatic triple-negative breast cancer.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-31704-7
- By:
- Publication type:
- Article
Analyses of hypoxia-related risk factors and clinical relevance in breast cancer.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1350426
- By:
- Publication type:
- Article
Machine learning models based on immunological genes to predict the response to neoadjuvant therapy in breast cancer patients.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.948601
- By:
- Publication type:
- Article
Machine learning models based on immunological genes to predict the response to neoadjuvant therapy in breast cancer patients.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.948601
- By:
- Publication type:
- Article
Cancer stem cell regulated phenotypic plasticity protects metastasized cancer cells from ferroptosis.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29018-9
- By:
- Publication type:
- Article
Unraveling the Expression Patterns of Immune Checkpoints Identifies New Subtypes and Emerging Therapeutic Indicators in Lung Adenocarcinoma.
- Published in:
- Oxidative Medicine & Cellular Longevity, 2022, p. 1, doi. 10.1155/2022/3583985
- By:
- Publication type:
- Article
A pooled analysis of clinical outcome in driver-gene negative non-small cell lung cancer patients with MET overexpression treated with gumarontinib.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241264730
- By:
- Publication type:
- Article
Hetrombopag for the management of chemotherapy-induced thrombocytopenia in patients with advanced solid tumors: a multicenter, randomized, double-blind, placebo-controlled, phase II study.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241260985
- By:
- Publication type:
- Article
MDM2 SNP309 Polymorphism and Colorectal Cancer Risk: Appraisal of a Recent Meta-Analysis.
- Published in:
- DNA & Cell Biology, 2012, v. 31, n. 3, p. 269, doi. 10.1089/dna.2011.1474
- By:
- Publication type:
- Article
Lack of Association Between CDH1 C−160A Genetic Polymorphism and Gastric Cancer Risk Among Asian Population.
- Published in:
- DNA & Cell Biology, 2012, v. 31, n. 3, p. 274, doi. 10.1089/dna.2011.1495
- By:
- Publication type:
- Article
Three Genetic Polymorphisms of Homocysteine-Metabolizing Enzymes and Risk of Coronary Heart Disease: Appraisal of a Recent Meta-Analysis.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Pharmacokinetics, pharmacodynamics and efficacy of pemigatinib (a selective inhibitor of fibroblast growth factor receptor 1–3) monotherapy in Chinese patients with advanced solid tumors: a phase i clinical trial.
- Published in:
- Investigational New Drugs, 2023, v. 41, n. 6, p. 808, doi. 10.1007/s10637-023-01396-x
- By:
- Publication type:
- Article
Low CD1c expression is associated with poor prognosis and immune infiltration in breast cancer.
- Published in:
- Chinese Journal of Immunology, 2024, v. 40, n. 2, p. 283, doi. 10.3969/j.issn.1000-484X.2024.02.011
- By:
- Publication type:
- Article
Paracrine secretion of IL8 by breast cancer stem cells promotes therapeutic resistance and metastasis of the bulk tumor cells.
- Published in:
- Cell Communication & Signaling, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12964-023-01068-6
- By:
- Publication type:
- Article
On-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trial.
- Published in:
- Molecular Cancer, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12943-021-01479-4
- By:
- Publication type:
- Article
Camrelizumab plus famitinib in previously chemo-immunotherapy treated patients with advanced NSCLC: results from an open-label multicenter phase 2 basket study.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 7, p. 1, doi. 10.1007/s00262-024-03715-4
- By:
- Publication type:
- Article
Relationship between Helicobacter pylori infection and vomiting induced by gastrointestinal cancer chemotherapy.
- Published in:
- Internal Medicine Journal, 2017, v. 47, n. 7, p. 792, doi. 10.1111/imj.13428
- By:
- Publication type:
- Article
Surufatinib in Chinese Patients with Locally Advanced or Metastatic Differentiated Thyroid Cancer and Medullary Thyroid Cancer: A Multicenter, Open-Label, Phase II Trial.
- Published in:
- Thyroid, 2020, v. 30, n. 9, p. 1245, doi. 10.1089/thy.2019.0453
- By:
- Publication type:
- Article
Effectiveness and Safety of Palbociclib Plus Endocrine Therapy in Patients with Advanced Breast Cancer: A Multi-Center Study in China.
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4360, doi. 10.3390/cancers15174360
- By:
- Publication type:
- Article
The Context-Dependent Impact of Integrin-Associated CD151 and Other Tetraspanins on Cancer Development and Progression: A Class of Versatile Mediators of Cellular Function and Signaling, Tumorigenesis and Metastasis.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2005, doi. 10.3390/cancers13092005
- By:
- Publication type:
- Article
Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer: The ORIENT-16 Randomized Clinical Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 21, p. 2064, doi. 10.1001/jama.2023.19918
- By:
- Publication type:
- Article
Pyrotinib plus capecitabine for trastuzumab-resistant, HER2-positive advanced breast cancer (PICTURE): a single-arm, multicenter phase 2 trial.
- Published in:
- BMC Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12916-023-02999-0
- By:
- Publication type:
- Article
Initial ribociclib plus endocrine therapy for HR+/HER2− advanced breast cancer in pre‐ and postmenopausal Chinese women: Primary results from a phase 2 randomized study.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 15, p. 1, doi. 10.1002/cam4.7408
- By:
- Publication type:
- Article
An autophagic gene‐based signature to predict the survival of patients with low‐grade gliomas.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 5, p. 1848, doi. 10.1002/cam4.3748
- By:
- Publication type:
- Article
A Phase IIb, single arm, multicenter trial of sacituzumab govitecan in Chinese patients with metastatic triple‐negative breast cancer who received at least two prior treatments.
- Published in:
- International Journal of Cancer, 2023, v. 152, n. 10, p. 2134, doi. 10.1002/ijc.34424
- By:
- Publication type:
- Article
Intravenous flurbiprofen axetil can increase analgesic effect in refractory cancer pain.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2009, v. 28, p. 1, doi. 10.1186/1756-9966-28-33
- By:
- Publication type:
- Article
Knockdown of CENPK inhibits cell growth and facilitates apoptosis via PTEN‐PI3K‐AKT signalling pathway in gastric cancer.
- Published in:
- Journal of Cellular & Molecular Medicine, 2021, v. 25, n. 18, p. 8890, doi. 10.1111/jcmm.16850
- By:
- Publication type:
- Article
Nimotuzumab Combined with Chemotherapy is a Promising Treatment for Locally Advanced and Metastatic Esophageal Cancer.
- Published in:
- Medical Science Monitor, 2017, v. 23, p. 412, doi. 10.12659/MSM.902645
- By:
- Publication type:
- Article
Pretreatment systemic inflammation response index is predictive of pathological complete response in patients with breast cancer receiving neoadjuvant chemotherapy.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Novel key genes in triple‐negative breast cancer identified by weighted gene co‐expression network analysis.
- Published in:
- Journal of Cellular Biochemistry, 2019, v. 120, n. 10, p. 16900, doi. 10.1002/jcb.28948
- By:
- Publication type:
- Article
artificial neural network model based on DNA damage response genes to predict outcomes of lower-grade glioma patients.
- Published in:
- Briefings in Bioinformatics, 2021, v. 22, n. 6, p. 1, doi. 10.1093/bib/bbab190
- By:
- Publication type:
- Article
Antitumor activity of high-dose pulsatile gefitinib in non-small-cell lung cancer with acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors.
- Published in:
- Experimental & Therapeutic Medicine, 2017, v. 13, n. 6, p. 3067, doi. 10.3892/etm.2017.4356
- By:
- Publication type:
- Article
An Immune-Associated Genomic Signature Effectively Predicts Pathologic Complete Response to Neoadjuvant Paclitaxel and Anthracycline-Based Chemotherapy in Breast Cancer.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.704655
- By:
- Publication type:
- Article
FOXA1‐induced LINC00621 promotes lung adenocarcinoma progression via activating the TGF‐β signaling pathway.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 21, p. 2026, doi. 10.1111/1759-7714.14986
- By:
- Publication type:
- Article
Synergistic effects of combined treatment with simvastatin and exemestane on MCF-7 human breast cancer cells.
- Published in:
- Molecular Medicine Reports, 2015, v. 12, n. 1, p. 456, doi. 10.3892/mmr.2015.3406
- By:
- Publication type:
- Article
Application consensus of peripheral blood HER2 gene amplification detection (digital PCR) in anti-HER2 therapy.
- Published in:
- China Oncology, 2022, v. 32, n. 1, p. 90, doi. 10.19401/j.cnki.1007-3639.2022.01.012
- By:
- Publication type:
- Article
LAMTOR5-AS1 regulates chemotherapy-induced oxidative stress by controlling the expression level and transcriptional activity of NRF2 in osteosarcoma cells.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 12, p. 1, doi. 10.1038/s41419-021-04413-0
- By:
- Publication type:
- Article
Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer: The ASTRUM-005 Randomized Clinical Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2022, v. 328, n. 12, p. 1223, doi. 10.1001/jama.2022.16464
- By:
- Publication type:
- Article
A multicenter, randomized trial comparing efficacy and safety of paclitaxel/capecitabine and cisplatin/capecitabine in advanced gastric cancer.
- Published in:
- Gastric Cancer, 2018, v. 21, n. 5, p. 782, doi. 10.1007/s10120-018-0809-y
- By:
- Publication type:
- Article
Pan-cancer and single-cell analysis reveals FAM83D expression as a cancer prognostic biomarker.
- Published in:
- Frontiers in Genetics, 2022, v. 13, p. 1, doi. 10.3389/fgene.2022.1009325
- By:
- Publication type:
- Article
Predicting pathologic response to neoadjuvant chemotherapy in patients with locally advanced breast cancer using multiparametric MRI.
- Published in:
- BMC Medical Imaging, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12880-021-00688-z
- By:
- Publication type:
- Article
Paclitaxel liposome for injection (Lipusu) plus cisplatin versus gemcitabine plus cisplatin in the first‐line treatment of locally advanced or metastatic lung squamous cell carcinoma: A multicenter, randomized, open‐label, parallel controlled clinical study
- Published in:
- Cancer Communications, 2022, v. 42, n. 1, p. 3, doi. 10.1002/cac2.12225
- By:
- Publication type:
- Article
MicroRNA-26a inhibits cell proliferation and invasion by targeting FAM98A in breast cancer.
- Published in:
- Oncology Letters, 2021, v. 21, n. 5, p. N.PAG, doi. 10.3892/ol.2021.12628
- By:
- Publication type:
- Article
Expression Patterns of Ezrin and AJAP1 and Clinical Significance in Breast Cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.831507
- By:
- Publication type:
- Article
Utilization of circulating cell-free DNA profiling to guide first-line chemotherapy in advanced lung squamous cell carcinoma.
- Published in:
- Theranostics, 2021, v. 11, n. 1, p. 257, doi. 10.7150/thno.51243
- By:
- Publication type:
- Article
Study of efficacy and safety of pulsatile administration of high-dose gefitinib or erlotinib for advanced non-small cell lung cancer patients with secondary drug resistance: A single center, single arm, phase II clinical trial.
- Published in:
- Thoracic Cancer, 2016, v. 7, n. 6, p. 663, doi. 10.1111/1759-7714.12384
- By:
- Publication type:
- Article
Prognostic role of LSD1 in various cancers: evidence from a meta-analysis.
- Published in:
- OncoTargets & Therapy, 2015, v. 8, p. 2565, doi. 10.2147/OTT.S89597
- By:
- Publication type:
- Article
Chinese expert consensus on the clinical diagnosis and treatment of advanced breast cancer (2018).
- Published in:
- 2020
- By:
- Publication type:
- journal article